Management guidelines for uninvestigated and functional dyspepsia in the Asia-Pacific region: First Asian Pacific working party on functional dyspepsia

被引:48
作者
Talley, NJ [1 ]
Lam, SK
Goh, KL
Fock, KM
机构
[1] Univ Sydney, Nepean Hosp, Dept Med, Penrith, NSW 2751, Australia
[2] Univ Hong Kong, Queen Mary Hosp, Hong Kong, Peoples R China
[3] Univ Malaya, Kuala Lumpur, Malaysia
[4] Univ Hosp, Kuala Lumpur, Malaysia
[5] Natl Univ Singapore, Fac Med, Singapore 117548, Singapore
[6] New Changi Hosp, Singapore, Singapore
关键词
antisecretory cisapride; domperidone; endoscopy; functional dyspepsia; H-2; blocker; H-pylori; management trials; non-ulcer dyspepsia; prokinetic; proton pump inhibitor;
D O I
10.1111/j.1440-1746.1998.tb00644.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Dyspepsia is most optimally defined as pain or discomfort centred in the upper abdomen. The symptom complex may be caused by peptic ulcer disease, gastro-oesophageal reflux, or gastric cancer but is most often due to functional (or non-ulcer) dyspepsia. While upper endoscopy is the method of choice to determine the underlying cause of dyspepsia, it is expensive. A more pragmatic approach is needed in the Asia-Pacific region where health services are limited. A detailed treatment algorithm is given for managing patients presenting with new-onset dyspepsia and documented functional dyspepsia after endoscopy, and evidence to support this approach is reviewed. Prompt endoscopy is recommended for patients with alarm fea-tures. In patients without alarm features, treatment for 2-4 weeks with an empirical anti-secretory or prokinetic agent, followed by investigation using non-invasive Helicobacter pylori testing and treatment for patients who do not respond or relapse, is recommended. Trials of management strategies are now needed to establish the efficacy and cost-effectiveness of the approaches recommended.
引用
收藏
页码:335 / 353
页数:19
相关论文
共 123 条
[1]  
AGORASTOS I, 1991, CURR THER RES CLIN E, V49, P870
[2]   Challenges in managing dyspepsia in general practice [J].
Agreus, L ;
Talley, N .
BRITISH MEDICAL JOURNAL, 1997, 315 (7118) :1284-1288
[3]   A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED TRIAL OF CISAPRIDE IN SAUDI ARABS WITH FUNCTIONAL DYSPEPSIA [J].
ALQUORAIN, A ;
LARBI, EB ;
ALSHEDOKI, F .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1995, 30 (06) :531-534
[4]  
ARCHIMANDRITIS A, 1992, CLIN THER, V14, P553
[5]  
BAILEY RJ, 1990, TODAYS THER TRENDS, V7, P1
[6]  
BAOEN W, 1995, CHIN J INT MED, V34, P180
[7]   STUDY OF DYSPEPSIA IN A GENERAL-PRACTICE AS ASSESSED BY ENDOSCOPY AND RADIOLOGY [J].
BARNES, RJ ;
GEAR, MWL ;
NICOL, A ;
DEW, AB .
BRITISH MEDICAL JOURNAL, 1974, 4 (5938) :214-216
[8]  
BOSSECKERT H, 1995, GUT, V37, pA139
[9]   EMPIRICAL H-2-BLOCKER THERAPY OR PROMPT ENDOSCOPY IN MANAGEMENT OF DYSPEPSIA [J].
BYTZER, P ;
HANSEN, JM ;
DEMUCKADELL, OBS .
LANCET, 1994, 343 (8901) :811-816
[10]  
Canepa G, 1991, Minerva Med, V82, P371